# An Evaluation of Safety of the Fentanyl Transdermal System for Management of Acute Post-Operative Pain in Pediatric Patients

> **NCT00666393** · PHASE3 · WITHDRAWN · sponsor: **Alza Corporation, DE, USA**

## Conditions studied

- Pain, Postoperative
- Pediatrics

## Interventions

- **DRUG:** fentanyl iontophoretic transdermal system (40mcg) No placebo
- **DRUG:** fentanyl iontophoretic transdermal system (40mcg)

## Key facts

- **NCT ID:** NCT00666393
- **Lead sponsor:** Alza Corporation, DE, USA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-10
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Program Cancelled.
- **Last updated:** 2014-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00666393

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00666393, "An Evaluation of Safety of the Fentanyl Transdermal System for Management of Acute Post-Operative Pain in Pediatric Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00666393. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*